Rajavtihi Neuronal Adult Stem Cells Project

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE2

Study Classification

INTERVENTIONAL

Study Start Date

2009-07-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To study the success of Oligodendrocyte progenitor cell culture project in Rajavithi Hospital to identify an unlimited clone human neuronal progenitor stem cells from the human brain in the Biomolecular Research Center. This study aims to produce the reproductive clone of neuronal development protocols and advance projects. Neuronal cells such as pyramidal cells, oligodendrocyte, and dopaminergic neuron differentiation protocol/projects for treatment of Alzheimer's disease, Multiple sclerosis, and Parkinson's disease respectively in next phase of clinical trials.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Autologous Stem/Stromal Cells in Neurological Disorders and Disease

NCT03297177

Dementia Parkinson Altered Behavior in Alzheimer Disease +3 more

UNKNOWN NA

Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head

NCT00813267

Osteochondritis of the Femoral Head

UNKNOWN EARLY_PHASE1

Stem Cell Therapy in Traumatic Brain Injury

NCT02028104

Traumatic Brain Injury

WITHDRAWN PHASE1

Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy

NCT02854579

Hypoxic-Ischemic Encephalopathy

UNKNOWN NA

Stem Cell Therapy in Incurable Neurological Disorders

NCT02245776

Neurological; Disorder, Nervous System

WITHDRAWN PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer's Disease Parkinson's Disease Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Cell culture

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Progenitor Stem Cell Culture

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have elective craniotomy or.
* Patients who have elective ventriculostomy surgery or.
* Patients who have elective muscle biopsy or nerve biopsy.
* Patient who have emergency craniectomy for life threatening from emergency medical and surgical conditions such as Brain herniation or head injury

Exclusion Criteria

* Central nervous system infection for example tuberculous or any bacterial infection, Viral infection, fungal infection.
* Central nervous system Tumor, Malignancy and metastasis.

Minimum Eligible Age

20 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes